Browsing Tag
Oncology
318 posts
Can AstraZeneca’s collaboration with Turbine speed up ADC drug discovery through AI simulation?
AstraZeneca joins hands with AI biotech Turbine to revolutionize antibody-drug conjugate discovery using virtual disease models and lab-in-the-loop design.
OS Therapies reports statistically significant 75% two-year survival with OST-HER2, eyes 2026 FDA approval
Find out how OS Therapies’ OST-HER2 achieved 75 % two-year survival in osteosarcoma and could secure FDA approval by 2026.
Shuttle to enter $3.24bn AI pharmaceutical market via acquisition of Molecule.ai
Find out how Shuttle Pharmaceuticals’ $10 million acquisition of Molecule.ai could reshape its R&D strategy and redefine the $3.24 billion AI pharma landscape.
Genmab’s $8bn takeover of Merus: What it means for biotech M&A and the race to control antibody innovation
Find out how Genmab’s $8B acquisition of Merus and its petosemtamab asset is reshaping the oncology biotech race and investor sentiment today.
Why Merus is the hottest takeover target in oncology right now—Genmab said to be frontrunner
Genmab is reportedly close to acquiring Merus in a high-stakes biotech deal that could reshape the oncology sector. Read the full breakdown now.
Can Merck’s new Keytruda injection delay biosimilar threats and change cancer care forever?
Find out how Merck’s newly FDA-approved Keytruda QLEX injectable version aims to improve cancer care with faster, more convenient treatment. Read on.
Why Medicines Discovery Catapult and Crown Bioscience think their partnership will change oncology R&D
Discover how Medicines Discovery Catapult and Crown Bioscience are reshaping radiopharmaceutical drug discovery with a new integrated platform.
BioNTech stock jumps 8.66% after DB-1303 meets primary endpoint in breast cancer trial
BioNTech stock surged after DB-1303 met its Phase 3 endpoint in HER2-positive breast cancer. Find out what this means for global oncology strategy.
BeOne Medicines’ sonrotoclax trial hits primary endpoint in mantle cell lymphoma patients
BeOne Medicines’ sonrotoclax met its primary endpoint in mantle cell lymphoma, with positive Phase 1/2 trial results. Find out what this means for patients.
Can medicinal plants play a larger role in cancer treatment as awareness grows in India?
Can medicinal plants play a bigger role in cancer care? Explore their contribution to modern drugs, preventive nutrition, and India’s free online Cancer Information Service.